The CBI arrested Channappagouda and RML cardiology Professor Ajay Raj for taking bribes from medical equipment suppliers to use their products and stents
Pharma major Lupin Ltd on Thursday announced appointments of ex-Pfizer Chairman and CEO, Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors on its board. Kindler is currently the CEO of Centrexion Therapeutics, a privately-held biotechnology company, Senior Advisor to Blackstone, Operating Partner at ARTIS Ventures and Global Chair of GLG Institute, Lupin said in a regulatory filing. He brings over four decades of business experience holding leadership positions at some of the world's most recognised companies, including Pfizer, where he served as Chairman & Chief Executive Officer, as well as McDonald's Corporation and General Electric Company, the company added. Before that, he was a partner at law firm Williams & Connolly. Zulueta currently serves as Non-Executive Chairman of the board of directors of Interpharma Investments Ltd, the holding company of Zuellig Pharma, one of the largest healthcare services groups in Asia, Lupin said. He is also President ..
Founded in 2010, NephroPlus currently operates about 450 dialysis centres across three main countries: India, the Philippines, and Uzbekistan
The XIENCE Sierra is the latest generation of the XIENCE family of everolimus-eluting coronary stent systems
Many industry bodies too had become party to the case, urging the apex court to listen to their grievances as well
The acquisition comes as the hospital chain has been working towards expansion efforts. In September 2023, Manipal Hospitals had acquired an 84 per cent stake in Emami Group's AMRI Hospitals
In financial year 2023, Indegene reported Rs 2,306.13 crore in revenue from operations with a profit of Rs 266 crore
Advent and Apollo HealthCo have entered into a deal through which Advent will invest Rs 2,475 crore into Apollo HealthCo
The hospital claims that the costs of their treatments are significantly lower compared to traditional surgeries and modern medical treatments
The role of India in the medical product field represents both a unique opportunity and an important responsibility, the head of the US Food and Drug Administration has said, ahead of the annual India-US BioPharma & Healthcare Summit. The summit will take place in Boston later this week. Dr Robert Califf, US FDA Commissioner will be one of the keynote speakers at the 18th edition of the annual largest gathering of pharma and healthcare sectors from the two countries, organised by USA India Chamber of Commerce. During the day-long summit, Dr Califf will share insights from his significant visit to India last September, which holds paramount importance for both countries, USA India Chamber of Commerce said in a statement on Sunday. I recently visited India with a central purpose in mindto strengthen our collective efforts to advance the development and availability of medical products that both our countries and the rest of the world need, he said. I knew, going into my trip, that .
Cipla Health strengthens beauty play in Tier II-VI towns with Ivia Beaute's cosmetics, personal care distribution and marketing biz
A portable cold chain solution for last-mile vaccine delivery
Even as the top pharmaceutical peers delivered a double digit growth in the December quarter, sales for GSK Pharma at Rs 805 crore was flat
Manipal Health Enterprises (Manipal Hospitals) currently operates 9,500 beds across 33 hospitals in India. Medica has a presence in eastern India with 1,200 beds
Under the agreement, Dr Reddy's will market Vericiguat under the brand name Gantra
Under the deal, J&J would pay $335 per share in cash for the medical device maker. The offer price implies a 4.7% premium to Shockwave's last close of $319.99 on Thursday
Srivastava added that telesurgery will allow surgeons to perform procedures on patients who are not physically present in the same location as them
Looking back, moving on: Doctors, nurses, ambulance drivers say Covid-19 has left them life-altering lessons
South Korea is poised to start suspending the licenses of thousands of striking junior doctors as a punitive measure against their weekslong walkouts that have shaken hospital operations. Starting next week, the government said it will inform the striking medical interns and residents of its final decision to suspend their licenses for missing a government-imposed February 29 deadline to return to work. It's still unclear whether the move will prompt the doctors to end their strikes, and the standoff could still deepen as some senior doctors plan to submit resignations on Monday in a show of solidarity with the junior strikers. Here are the latest developments on the strikes touched off by the government's announcement in early February that it would recruit 2,000 more medical students yearly. WHY ARE THEIR LICENSES BEING SUSPENDED? Since early March, the South Korean government has been taking a series of administrative steps to suspend the licenses of about 12,000 junior doctors
IHH launches new identity Gleneagles Hospitals replacing Gleneagles Global Hospitals